Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_assertion type Assertion NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_head.
- NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_assertion description "[The aberrant expression of KLKs, presented in many human malignancies, highlights the significance of this gene family for early diagnosis, prognosis and monitoring of cancer patients, as it is strongly emphasized by the routine use of PSA (KLK3) for prostate cancer management.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_provenance.
- NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_assertion evidence source_evidence_literature NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_provenance.
- NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_assertion SIO_000772 20302518 NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_provenance.
- NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_assertion wasDerivedFrom befree-20150227 NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_provenance.
- NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_assertion wasGeneratedBy ECO_0000203 NP825689.RAvqUuDB5POkcPA-hZmYZJLawXbL4_9B5wA0vjd8nvlDk130_provenance.